{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:09:42Z","timestamp":1761394182752},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1212\/wnl.45.9.1735","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:17:18Z","timestamp":1336915038000},"page":"1735-1738","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Positron emission tomography study of human narcolepsy"],"prefix":"10.1212","volume":"45","author":[{"given":"J. O.","family":"Rinne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hublin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Partinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ruottinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Ruotsalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nagren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lehikoinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Laihinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.1.1"},{"key":"e_1_3_1_3_2","first-page":"5","volume":"43","year":"1974","unstructured":"Parkes JD, Fenton G, Struthers G, et al. Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med 1974;43:525-536.","journal-title":"Q J Med"},{"key":"e_1_3_1_4_2","first-page":"4","volume":"9","year":"1986","unstructured":"Godbout R, Montplaisir J. The effect of zimelidine, a serotonin-reuptake blocker, on cataplexy and daytime sleepiness of narcoleptic patients. Clin Neuropharmacol 1986;9:46-51.","journal-title":"Clin Neuropharmacol"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90301-Q"},{"key":"e_1_3_1_6_2","unstructured":"Baker TL Dement WC. Canine narcolepsy-cataplexy syndrome: evidence for an inherited monoaminergic-cholinergic imbalance. In: McGinty DJ Drucker-Colin R Morrison A Parmeggiani PL eds. Brain mechanisms of sleep. New York: Raven Press 1985;199-234."},{"key":"e_1_3_1_7_2","first-page":"4","volume":"402","year":"1987","unstructured":"Bowersox SS, Kilduff TS, Faull KF, Zeller-DeAmicis L, Dement WC, Ciaranello RD. Brain dopamine receptor levels elevated in canine narcolepsy. Brain Res 1987;402:44-48.","journal-title":"Brain Res"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-04-j0002.1991"},{"key":"e_1_3_1_9_2","first-page":"2","volume":"42","year":"1992","unstructured":"Kish SJ, Mamelak M, Slimovitch C, et al. Brain neurotransmitter changes in human narcolepsy. Neurology 1992;42:229-234.","journal-title":"Neurology"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"20","year":"1991","unstructured":"Aldrich MS, Hollingsworth Z, Penney JB. Adrenergic receptor autoradiography of human narcoleptic brain [abstract]. Sleep Res 1991;20A:280.","journal-title":"Sleep Res"},{"key":"e_1_3_1_11_2","first-page":"4","volume":"42","year":"1992","unstructured":"Aldrich MS, Hollingsworth Z, Penney JB. Dopamine-receptor autoradiography of human narcoleptic brain. Neurology 1992;42:410-415.","journal-title":"Neurology"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"9","year":"1986","unstructured":"Carskadon MA. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-524.","journal-title":"Sleep"},{"key":"e_1_3_1_13_2","unstructured":"Rechtschaffen A Kales A eds. A manual of standardized terminology techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service\/Brain Research Institute University of California Los Angeles 1968."},{"key":"e_1_3_1_14_2","first-page":"8","volume":"18","year":"1991","unstructured":"Halldin C, Farde L, Hogberg T, et al. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. J Nucl Biol Med 1991;18:871-881.","journal-title":"J Nucl Biol Med"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1993.3"},{"key":"e_1_3_1_16_2","unstructured":"Aquilonius S-M Eckernas S-A. A colour atlas of the human brain. Adapted to computed tomography. Stockholm: Esselte Studium 1980."},{"key":"e_1_3_1_17_2","first-page":"6","volume":"8","year":"1989","unstructured":"Farde L, Eriksson L, Blomqvist G, Halldin C. Kinetic analysis of central [(11) C]raclopride binding to D2-dopamine receptors studied with PET--a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 1989;8:696-708.","journal-title":"J Cereb Blood Flow Metab"},{"key":"e_1_3_1_18_2","first-page":"6","volume":"51","year":"1949","unstructured":"Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-672.","journal-title":"Ann NY Acad Sci"},{"key":"e_1_3_1_19_2","unstructured":"Gardner MJ Altman DG eds. Statistics with confidence. London: British Medical Journal 1992."},{"key":"e_1_3_1_20_2","first-page":"1","volume":"90","year":"1995","unstructured":"Hublin C, Launes J, Nikkinen P, Partinen M. Dopamine D2-receptors in human narcolepsy: a SPECT study with123 I-IBZM. Acta Neurol Scand 1995;90:186-189.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_21_2","unstructured":"Stoppe G Staedt J Kogler A et al. In vivo imaging of dopamine D2 receptors in human narcolepsy [abstract]. J Sleep Res 1994;3(suppl 1):242."},{"key":"e_1_3_1_22_2","unstructured":"Khan N Antonini A Parkes JD et al. Dopamine D2 receptors in narcolepsy: a PET study [abstract]. J Sleep Res 1994;3(suppl 1):127."},{"key":"e_1_3_1_23_2","unstructured":"MacFarlane JG Chabursky B Houle S. Striatal dopamine D1 and D2 receptor binding in treatment-naive human narcoleptics using PET [abstract]. J Sleep Res 1994;3(suppl 1):153."},{"key":"e_1_3_1_24_2","unstructured":"DeRecondo A Laffont F Loc'h C Ottaviani M Samson Y. Positron emission tomography study of striatal dopaminergic receptors in human narcolepsy [abstract]. Neurology 1992;42(suppl 3):434."},{"key":"e_1_3_1_25_2","unstructured":"Diagnostic Classification Steering Committee. ICSD - International classification of sleep disorders: diagnostic and coding manual. Rochester MN: American Sleep Disorders Association 1990."},{"key":"e_1_3_1_26_2","first-page":"5","volume":"43","year":"1993","unstructured":"Moscovitch A, Partinen M, Guilleminault C. The positive diagnosis of narcolepsy and narcolepsy's borderland. Neurology 1993;43:55-60.","journal-title":"Neurology"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(68)90060-6"},{"key":"e_1_3_1_28_2","unstructured":"Passouant P Billiard M. The evolution of narcolepsy with age. In: Guilleminault C Dement WC Passouant P eds. Narcolepsy. New York: Spectrum Publications 1976:179-196."},{"key":"e_1_3_1_29_2","first-page":"1","volume":"12","year":"1990","unstructured":"Rosenthal LD, Merlotti L, Young DK, et al. Subjective and polysomnographic characteristics of patients diagnosed with narcolepsy. Gen Hosp Psychiatry 1990;12:191-197.","journal-title":"Gen Hosp Psychiatry"},{"key":"e_1_3_1_30_2","first-page":"6","volume":"16","year":"1979","unstructured":"Peroutka SJ, Snyder SH. Multiple serotonin receptors: differential binding of [(3) H]5-hydroxytryptamine, [(3) H]lysergic acid diethylamide and [(3) H]spiroperidol. Mol Pharmacol 1979;16:687-699.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_1_31_2","first-page":"5","volume":"15","year":"1979","unstructured":"Howlett DR, Morris H, Nahorski SR. Anomalous properties of [(3) H]spiperone binding sites in various areas of the rat limbic system. Mol Pharmacol 1979;15:506-514.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1984.tb06671.x"},{"key":"e_1_3_1_33_2","first-page":"2","volume":"43","year":"1984","unstructured":"Seeman P, Ulpian C, Wreggert KA, Wells JW. Dopamine receptor parameters detected by3 H-spiperone depend on tissue concentration: analysis and examples. J Neurochem 1984;43:221-235.","journal-title":"J Neurochem"},{"key":"e_1_3_1_34_2","first-page":"5","volume":"65","year":"1986","unstructured":"Rinne JO, Sako E, Paljarvi L, Molsa P, Rinne UK. Brain dopamine D-2 receptors in senile dementia. J Neural Transm 1986;65:51-62.","journal-title":"J Neural Transm"},{"key":"e_1_3_1_35_2","first-page":"4","volume":"50","year":"1993","unstructured":"Antonini A, Leenders KL, Reist H, Thomann R, Beer H-F, Locher J. Effect of age on dopamine D2 receptors in normal human brain measured by positron emission tomography and11 C-raclopride. Arch Neurol 1993;50:474-480.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_36_2","first-page":"1","volume":"226","year":"1984","unstructured":"Wong DF, Wagner HN, Dannals RE, et al. Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 1984;226:1393-1396.","journal-title":"Science"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.9.1735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:56:02Z","timestamp":1711641362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.9.1735"}},"subtitle":["No increase in striatal dopamine D\n            <sub>2<\/sub>\n            receptors"],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["10.1212\/WNL.45.9.1735"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.9.1735","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}